Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) โ Board Meeting | 8 September 2026 (2 announcements)
Aarey Drugs & Pharmaceuticals announced a book closure for its 36th Annual General Meeting scheduled from 24 to 30 September 2026, during which the Register of Members and Share Transfer books will remain closed for record-keeping purposes.
Aarey Drugs & Pharmaceuticals announced its 36th Annual General Meeting on September 30, 2026 at 3:00 PM via video conferencing, accompanied by the Integrated Annual Report for FY 2025-26. Shareholders will vote on adopting the audited financial statements for March 31, 2026, appointing Director Bina Ghatalia, and approving related party transactions totaling up to โน150 crores across 11 entities. The meeting will use e-voting with a cut-off date of September 23, 2026, and physical attendance is dispensed with per regulatory relaxations.
About Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)
Healthcare ยท Pharmaceuticals ยท Listed on BSE
๐ก Get AI alerts when AAREYDRUGS files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track AAREYDRUGS โ Free๐ก Ask AI about this filing
๐ More AAREYDRUGS filings
- Announcement โ 23 September 2026Aarey Drugs & Pharmaceuticals announced that its insider trading window will close on October 1, 202...
- ๐ด Annual Report โ 11 September 2026Aarey Drugs & Pharmaceuticals disclosed that its integrated annual report for FY2025-26 is available...
- ๐ก Board Meeting โ 5 September 2026Aarey Drugs & Pharmaceuticals announced its board approved the draft annual report and scheduled the...
- ๐ก Board Meeting โ 14 August 2026The board approved unaudited Q1 FY26 standalone financial results showing revenue of [amount not ver...
- Financial Results โ 26 June 2026Aarey Drugs & Pharmaceuticals Limited announced that its trading window closes on July 1, 2026, for ...
๐ฅ Also filed on 8 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when AAREYDRUGS files new disclosures
Track AAREYDRUGS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AAREYDRUGS โ FreeFree account ยท 2 AI queries/day